Gastrointestinal Cancer Update
by Dr Neil Love
April 17, 2024 2:57 am
This series bridges the gap between research and patient care by providing medical oncologists and hematologists with ongoing access to the perspectives and opinions of national and international clinical investigators with expertise in gastrointestinal cancers.
Recent Episodes
Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition
1 week agoYear in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer
2 weeks agoConsensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers — A 2024 Post-ASCO Gastrointestinal Cancers Symposium Review
1 month agoYear in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gastroesophageal Cancers
2 months agoConsensus or Controversy? Investigator Perspectives on the Current and Future Role of Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers
2 months agoInside the Issue: Targeted and Immunotherapeutic Approaches for Biliary Tract Cancers
4 months agoMeet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 3 of a 3-Part Series
5 months agoMeet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 2 of a 3-Part Series
5 months agoMeet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 1 of a 3-Part Series
6 months agoOncology Today with Dr Neil Love: Management of Metastatic Pancreatic Cancer with Dr Michael Pishvaian
6 months ago